CGTN: China: Race to the Future
BEIJING,Sept. 18,2024-- "China: Race to the Future" is a five-part documentary series focusing on China\'s remarkable transformation since the founding of the People\'s Republic. Broadcast o
xTool Celebrates 4th Anniversary with Newly Launched P2S and Year's Best Deals
IRWINDALE,Calif.,Sept. 18,2024-- xTool,a rapidly growing trailblazer and global leader in the laser cutter and engraver industry,is thrilled to celebrate its 4th anniversary with its community of 255,
Catch a Glimpse of The Madison 2024 September Live Auction
HONG KONG and BEIJING,Sept. 19,2024-- Following the success of Madison Mid-Autumn Auction in August 2024,Madison Auction is pleased to present our September live sale,which will be held at GrandHyatt
Fan-tastic Journeys: Sports and Music Events Take Fans to New Destinations
Priority Pass shares what sports and music fans want from their travel experiences. • Over three-quarters (80%) of sports and music fans in Asia Pacific (APAC) travelled to an event by plane in the
Tineco Expands PURE ONE Portfolio with Two New Cutting-Edge Cordless Smart Vacuums
Revolutionizing Clean with Advanced Capabilities and Superior Performance SEATTLE,Sept. 17,2024-- Tineco,a global leader in intelligent home appliances with an emphasis on innovative floor care items,
With this collaboration,Respiree\'s patient monitoring solution will be made available for healthcare professionals in APAC through a pilot program using Roche\'s blood glucose monitoring system. The
Ascenda partners with Uber for first-of-a-kind points redemption for consumers worldwide
NEW YORK,Sept. 17,2024--Ascenda,the global premium rewards network,today announced it has expanded its rewards network in order to enable fintech and banking clients\' customers to redeem their rewar
PISCATAWAY,N.J.,Sept. 15,2024-- The year 2024 marks a milestone year for continuous advancements in Cell and Gene Therapy (CGT). The global launch of Amtagvi,a Tumor-Infiltrating Lymphocyte (TIL) ther
In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs),ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an ov
Autoliv Appoints Adriana Karaboutis to its Board of Directors
STOCKHOLM,Sept. 16,2024-- Autoliv,Inc. (NYSE: ALV)(SSE: ALIVsdb),the worldwide leader in automotive safety systems,announces that it has added a new independent member to its Board of Directors effect